What is the main business of Biochem Technologies?

The main business activity of Biochem Technologies focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 22, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Stanisława Sulimy 1, 82-300 Elbląg.

Who is on the management board?

The management board consists of: Bogdan Arkadiusz Lorenc (Member of the Management Board) and Cezariusz Konieczkowski (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 2,400,000 (approx. $648,298).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $2,047 in 2024, which is an increase of 1534.0% compared to 2023.

No, the company recorded a net loss of $121,575 in 2024. For comparison, in 2023 the loss was $20,782, meaning the company increased its loss by 455.6%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $36,463 in 2024, representing 33% of all operating expenses.

Biochem Technologiessp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-12-22

Share capital

2,400,000.00 PLN

Registered address

ul. Stanisława Sulimy 1, 82-300 Elbląg, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 93 days for 2024).

2025not filed
202416/10/2025
202314/08/2024
202229/08/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Research and experimental development on biotechnology312 / 386

Top 81%

Division · Scientific research and development1,640 / 1,953

Top 84%

Sector · Professional, scientific and technical activities35,053 / 39,215

Top 89%

Voivodeship · Warmińsko-Mazurskie8,376 / 9,258

Top 90%

Country · Poland441,355 / 495,850

Top 89%

Results vs industry

Revenue

This companyUSD 2.05kMedianUSD 55.24kAverageUSD 2.70m

Net profit

This companyUSD -121.58kMedianUSD -1.27kAverageUSD -92.18k

Operating costs

This companyUSD 109.75kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 593.34kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Bogdan Arkadiusz Lorenc – Management Board Member

Cezariusz Konieczkowski – Management Board Member

Manner of representation

A member of the management board for financial matters together with a second member of the management board (joint representation) is authorised to make declarations of will on behalf of the company and to represent it.

Supervisory board

Adam Andrzej Konieczkowski – Supervisory Board Member

Marcin Adam Podsiadło – Supervisory Board Member

Dariusz Robert Górka – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Biopangea sp. z o.o.	8,100	$218,800.65	33.75%
Varutis sp. z o.o.	15,150	$409,238.25	63.125%
Others	750	$20,259.32	3.125%

The articles of association require company consent for share transfers.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2023-09-01 to 2026-04-20.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication date	Event
Jan 28, 2026	Dissolution without liquidation opened

Public aid

Grant date	Purpose	Gross amount	Granting body
Dec 1, 2023	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$23,745$23,745	Prezydent Miasta Elbląg
Dec 1, 2023	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$3,682$3,682	Prezydent Miasta Elbląg
Dec 1, 2023	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$1,232$1,232	Prezydent Miasta Elbląg

Competitors

Name	Revenue	Website
Wstechnologysp. z o.o.	$258,318.71	wstechnology.pl
Biodecsp. z o.o.	$115,508.63	biodec.pl
Poltisssp. z o.o.	$3,843.72	poltiss.com
Omnisepticasp. z o.o.	$3,475.29	omniseptica.com
Plan Biosp. z o.o.	$3,404.49	biotrem.pl
Greenetoxsp. z o.o.	$3,013.95	greenetox.com
Passio Human Microbiomesp. z o.o.	$1,856.58	passiohumanmicrobiome.com
Dairy Biotechnologiessp. z o.o.	$1,485.09	milcu.eu
Medical Algorithmssp. z o.o.	$682.08	medicalalgorithms.eu
BioencaS.A.	$0.00	bioenca.pl

Change history

Date	Event
2024-02-06	Address change (Ul. Bojanowska 2b, 09-200, Sierpc → Ul. Stanisława Sulimy 1, 82-300, Elbląg)
2024-02-06	Share capital increase (10,000.00 PLN → 2,400,000.00 PLN)
2024-02-06	Name change (Maxlabor → Biochem Technologies)
2024-02-06	PKD change (Removed: 8 codes; Added: 9 codes)
2023-11-20	Address change (Ul. Bojanowska 2a, 09-200, Sierpc → Ul. Bojanowska 2b, 09-200, Sierpc)

FAQ

Last updated: 2026-05-14